SDS Biotech K.K. announced consolidated earnings results for the first quarter ended June 30, 2019. For the quarter, the company reported net sales of JPY 2,220 million as compared to JPY 2,431 million for the same period last year. Operating loss was JPY 2 million as compared to operating income of JPY 106 million for the same period last year. Net income was JPY 460 million as compared to JPY 21 million for the same period last year. Net income per share was JPY 58.78 as compared to JPY 2.78 for the same period last year.

The company provided earnings guidance for the full year ending March 31, 2020. The company expects net sales of JPY 13,550 million, operating income of JPY 1,110 million, net income of JPY 1,110 million and earnings per share of JPY 141.74.

The company provided dividend guidance for the second quarter of fiscal year 2020 and full year ending March 31, 2020. The company expects second quarter end dividend of JPY 12.50 per share compared to JPY 12.50 per share paid a year ago.

The company expects year-end dividend of JPY 12.50 per share for the full year ending March 31, 2020 compared to JPY 12.50 per share paid a year ago.